TFX - Heat Biologics Provides Update And Other News: The Good Bad And Ugly Of Biopharma
- Heat Biologics boosts patents portfolio with gp96 combination award.
- Teleflex announces acquisition of hemostatic company Z-Medica.
- Aerie Pharmaceuticals begins Phase 2b dry eye diseases clinical trial.
For further details see:
Heat Biologics Provides Update, And Other News: The Good, Bad And Ugly Of Biopharma